These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25268670)

  • 1. Interferon alfa-associated depression in patients with Behçet's syndrome: a prospective controlled study.
    Keskin Y; Seyahi E; Poyraz C; Ugurlu S; Ozyazgan Y; Yazici H
    Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S175. PubMed ID: 25268670
    [No Abstract]   [Full Text] [Related]  

  • 2. Low dose interferon-alpha to treat Behçet's disease.
    Thirion M; Miceli-Richard C; Labetoulle M; Mariette X
    Clin Exp Rheumatol; 2007; 25(5):791. PubMed ID: 18078636
    [No Abstract]   [Full Text] [Related]  

  • 3. Interferon-alpha in the management of patients with Behçet's disease.
    Yang DS; Taylor SR; Lightman SL
    Br J Hosp Med (Lond); 2008 Oct; 69(10):575-9. PubMed ID: 18949947
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of interferon alpha treatment on the clinical course of refractory Behçet's disease: an open study.
    Calgüneri M; Oztürk MA; Ertenli I; Kiraz S; Apraş S; Ozbalkan Z
    Ann Rheum Dis; 2003 May; 62(5):492-3. PubMed ID: 12695172
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferon alfa-2a in the treatment of ocular Adamantiades-Behçet's disease.
    Krause L; Turnbull JR; Torun N; Pleyer U; Zouboulis CC; Foerster MH
    Adv Exp Med Biol; 2003; 528():511-9. PubMed ID: 12918754
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuropsychiatric features in Behçet's disease: a case report.
    van Ham C; Schrijvers D; De Picker L; Vandendriessche F; Sabbe B
    Clin Neurol Neurosurg; 2014 Dec; 127():13-4. PubMed ID: 25306415
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of Behçet's disease with pathergy reaction at interferon injection site.
    Aral A; Onder M; Gürer MA
    Adv Exp Med Biol; 2003; 528():541-3. PubMed ID: 12918760
    [No Abstract]   [Full Text] [Related]  

  • 8. Suicidal ideation among patients with Behçet's syndrome.
    Saygin C; Uzunaslan D; Hatemi G; Hamuryudan V
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S30-5. PubMed ID: 25797433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose and dose escalating therapy of interferon alfa-2a in the treatment of refractory and sight-threatening Behçet's uveitis.
    Onal S; Kazokoglu H; Koç A; Akman M; Bavbek T; Direskeneli H; Yavuz S
    Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S113-4. PubMed ID: 19796551
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuropsychiatric side effects of interferon-alfa therapy.
    Van Gool AR; Kruit WH; Engels FK; Stoter G; Bannink M; Eggermont AM
    Pharm World Sci; 2003 Feb; 25(1):11-20. PubMed ID: 12661471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of interferon-alpha in Behçet's disease--review of the literature and possible mechanisms of action.
    Kötter I; Günaydin I; Treusch M; Zierhut M; Kanz L; Stübiger N
    Adv Exp Med Biol; 2003; 528():503-9. PubMed ID: 12918753
    [No Abstract]   [Full Text] [Related]  

  • 12. Interferon therapy for Behçet's disease.
    Alpsoy E; Yilmaz E; Başaran E
    J Am Acad Dermatol; 1994 Oct; 31(4):617-9. PubMed ID: 8089288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy and safety of low-dose and dose-escalating interferon alfa-2a therapy in refractory Behçet uveitis.
    Onal S; Kazokoglu H; Koc A; Akman M; Bavbek T; Direskeneli H; Yavuz S
    Arch Ophthalmol; 2011 Mar; 129(3):288-94. PubMed ID: 21402983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon alfa-2b, colchicine, and benzathine penicillin versus colchicine and benzathine penicillin in Behçet's disease: a randomised trial.
    Demiroglu H; Ozcebe OI; Barista I; Dündar S; Eldem B
    Lancet; 2000 Feb; 355(9204):605-9. PubMed ID: 10696980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-a (IFN-a) application versus tumor necrosis factor-a antagonism for ocular Behçet's disease: focusing more on IFN.
    Kotter I; Deuter C; Stubiger N; Zierhut M
    J Rheumatol; 2005 Aug; 32(8):1633; author reply 1634. PubMed ID: 16078350
    [No Abstract]   [Full Text] [Related]  

  • 16. Interferon-α treatment for acute myelitis and intestinal involvement in severe Behçet's disease.
    Monastirli A; Chroni E; Georgiou S; Ellul J; Pasmatzi E; Papathanasopoulos P; Tsambaos D
    QJM; 2010 Oct; 103(10):787-90. PubMed ID: 20650970
    [No Abstract]   [Full Text] [Related]  

  • 17. Rituximab is effective in severe treatment-resistant neurological Behçet's syndrome.
    Kidd DP
    J Neurol; 2015 Dec; 262(12):2676-7. PubMed ID: 26410745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of interferon-alpha treatment on serum IL-6, IL-8, TNF-alpha and soluble TNF-alpha receptors in Behçet's disease.
    Direskeneli H; Fresko I; Hamuryudan V
    Scand J Rheumatol; 2005; 34(1):75-6. PubMed ID: 15903033
    [No Abstract]   [Full Text] [Related]  

  • 19. Complete regression of retinal neovascularization after therapy with interferon alfa in Behçet's disease.
    Stuebiger N; Koetter I; Zierhut M
    Br J Ophthalmol; 2000 Dec; 84(12):1437-8. PubMed ID: 11186866
    [No Abstract]   [Full Text] [Related]  

  • 20. [Behçet's disease: uveitis-therapy with interferon alpha2a - prospective clinical study in 33 patients].
    Stübiger N; Kötter I; Deuter C; Zierhut M
    Klin Monbl Augenheilkd; 2001 Dec; 218(12):768-73. PubMed ID: 11805868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.